Daniel J. Char

Daniel Char practices at New Jersey Endovascular Therapeutics in Woodcliff Lake, New Jersey.

Daniel Char's NPI, 1366518128, was assigned on November 25, 2006. Daniel Char graduated from Renaissance School of Medicine at Stony Brook University in 1995. Daniel Char holds New Jersey license 25MA07372800.

Daniel Char's primary practice is New Jersey Endovascular Therapeutics, at 20 Carrington Ct, Woodcliff Lake, NJ 07677 in Bergen County. The practice phone is (201) 444-5353.

Daniel Char's primary practice is New Jersey Endovascular Therapeutics in Woodcliff Lake, New Jersey. Daniel Char is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is New Jersey Endovascular Therapeutics. Dmand AI also links Daniel Char to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Char practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Daniel Char's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Daniel Char is board certified in surgery by the American Board of Surgery. Dmand AI has Daniel Char's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, heart device and aorta surgery, leg revascularization and varicose vein treatment among the conditions Daniel Char treats.

CMS data shows 2,380 Medicare services from Daniel Char across 20 procedure codes in 2024, for 1,450 Medicare patients. Medicare paid $218,893 for them.

CMS counts 1,450 Medicare patients who saw Daniel Char in 2024. The largest group is 75 to 84, with 585 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Char's median patient age at 71, with 52% women.

In 2024, Daniel Char wrote 198 Medicare Part D claims for 76 patients. 68% of them were for generic drugs. CMS names the drug for 158 of them, across 4 drugs with 11 or more claims each, at $44,488 in total drug cost. In 2023, CMS named 159 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Daniel Char for performance year 2024, reported through an alternative payment model (APM). Daniel Char accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of leg revascularization (restoring blood flow) by Daniel Char, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Daniel Char, published from 2001 to 2003. The most frequent topics are Postoperative Complications, Endarterectomy, Carotid and Tomography, X-Ray Computed. Daniel Char has published most often in Vasc Endovascular Surg. Daniel Char's most frequent co-authors are Salvador A. Cuadra, MD, Fabio F. Giron, MD and Allison J. McLarty, MD.

CMS Open Payments shows 150 general payments to Daniel Char from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic Vascular, Inc. paid the most, $3,980.

Dmand AI lists 2 awards for Daniel Char.

Daniel Char graduated from Renaissance School of Medicine at Stony Brook University in 1995. Daniel Char is a member of ACS.

Daniel Char is in network with 2 carriers, including CMS Medicare and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.